Members

Nadine Shehata, Mount Sinai Hospital, Toronto, Canada (ICTMG Chair)

Arwa Al-Riyami, Sultan Qaboos University Hospital, Oman

Shubha Allard, NHS Blood and Transplant, United Kingdom

Melissa Brouwers, University of Ottawa, Canada

Jeannie Callum, Sunnybrook Health Science Centre, Canada

James Daly, Australian Red Cross Blood Services, Australia

Greg Denomme, Versiti Blood Centre of Wisconsin, United States

Lise Estcourt, NHS Blood & Transplant, United Kingdom

Dean Fergusson, Ottawa Hospital Research Institute, Canada

Mark Fung, University of Vermont Medical Centre, United States

Laura Green, NHS Blood and Transplant and Barts Health Trust, United Kingdom

Andreas Greinacher, University of Greifswald, Germany

Heather Hume, University of Montreal, Canada

Rachel Jug, Canadian Blood Services, Canada (trainee)

Richard Kaufman, Brigham & Woman's Hospital Transfusion Service, United States

Hyungsuk Kim, Seoul National University Hospital, Korea

Ursula La Rocca, Italian National Blood Center, Italy

Lani Lieberman, University of Toronto, Canada

Vernon Louw, Groote Schuur Hospital and University of Cape Town, South Africa

Tadashi Matsushita, Nagoya University Hospital, Japan

Michael Murphy, University of Oxford, United Kingdom

Susan Nahirniak, Alberta Public Laboratories and University of Alberta, Canada

Katerina Pavenski, St. Michael's Hospital and University of Toronto, Canada

Joanne Pink, Australian Red Cross Blood Services, Australia

Susan Robinson, Guy's and St. Thomas' NHS Foundation Trust, United Kingdom

Cynthia So-Osman, Sanquin and Erasmus Medical Center, The Netherlands

Simon Stanworth, NHS Blood and Transplant and Oxford University, United Kingdom

Zbigniew M. Szczepiorkowski, Dartmouth-Hitchcock Medical Center, United States

Aaron Tobian, John Hopkins University, United States

Erica Wood, Monash University, Australia

  • Nadine Shehata, MD, MSc, FRCPC
    Mount Sinai Hospital, University of Toronto, and Canadian Blood Services
    Canada

    Expertise: Dr. Shehata is a hematologist. Her research interests are in transfusion medicine as it relates to cardiovascular surgery and maternal fetal medicine, hematological disorders of pregnancy and evidence-based practice guidelines. Please view Dr. Shehata’s publications here.

     

    ICTMG connections: Dr. Shehata is ICTMG chair, member of all committees, and member of the guideline development groups for fetal/neonatal alloimmune thrombocytopenia (FNAIT), hemoglobinopathies, platelets, hemolytic disease of the newborn (HDN), and albumin. 

  • Arwa Al-Riyami, MD, FRCPC, @DrRiyamia

    Sultan Qaboos University Hospital

    Oman

    Expertise: Dr. Al-Riyami is a senior consultant hematopathologist. Her research centres on transfusion medicine and blood banking, medical education, and medical research and quality.  Please view Dr. Al-Riyami's publications here.

    ICTMG Connections:  Dr. Al-Riyami is a member of the Topics Committee.

  • Shubha Allard, MD, FRCP, FRCPath
    National Health Service Blood & Transplant
    United Kingdom

    Expertise: Dr. Allard is a consultant hematologist with a research interest in appropriate use of blood and blood components. Please view Dr. Allard’s publications here

    ICTMG connections: Dr. Allard is a member of the Topics Committee, the Dissemination and Implementation Committee, and the guideline development group for platelets

  • Melissa Brouwers, PhD

    University of Ottawa

    Canada

    Expertise:  Dr. Brouwers is a health sciences researcher with an interest in knowledge translation, implementation science and evaluation and director of the School of Epidemiology and Public Health at the University of Ottawa. Please view Dr. Brouwers' publications here.

    ICTMG connections:  Dr. Brouwers is a member of the Methods Committee

  • Jeannie Callum, MD, FRCPC, @JeannieCallum

    Sunnybrook Health Sciences Centre and University of Toronto

    Canada

    Expertise:  Dr. Callum is a transfusion medicine specialist and hematologist. Her research investigates the management of major hemorrhage, transfusion-related errors, and adverse consequences of transfusion. Please view Dr. Callum's publications here.

    ICTMG connections:  Dr. Callum is a member of the Dissemination and Implementation Committee, a member of the guideline development group for platelets, and the co-chair of the guideline development group for albumin.

  • James Daly, MBBS, FRACP, FRCPA

    Australian Red Cross Lifeblood

    Australia

    Expertise:  Dr. Daly is a clinical and laboratory haematologist and medical director of pathology services at Australian Red Cross Lifeblood. Please view Dr. Daly's publications here.

    ICTMG connections:  Dr. Daly is the co-chair of the Dissemination and Implementation Committee and a member of the Executive and the Editorial committees.

  • Greg Denomme, PhD, FCSMLS(D), @GregDenomme

    Versiti Blood Centre of Wisconsin

    United States

    Expertise:  Dr. Denomme is a clinical and academic trained scientist. His research examines the molecular basis of blood group antigens and the application of molecular immunohematology in the diagnosis of immune-mediated hemolytic anemia. Please view Dr. Denomme’s publications here.

    ICTMG connections:  Dr. Denomme is a member of the Topics Committee, and a member of the guideline development group for hemoglobinopathies.

  • Lise Estcourt, MB BChir, MA(Cantab), MA(MEL), MSc, DLSHTM, DPhil, MRCP, FRCPath, @AndelLestcourt

    National Health Service Blood & Transplant
    United Kingdom

    Expertise:  Dr. Estcourt is a consultant hematologist.  Her research focuses on the safe and effective use of blood components in patients with hematological disorders. Please view Dr. Estcourt’s publications here.

    ICTMG connections:  Dr. Escourt is a member of the Methods Committee, and a member of the guideline development group for platelets.

  • Dean Fergusson, PhD, MHA

    Ottawa Hospital Research Institute
    Canada

    Expertise:  Dr. Fergusson is a senior scientist and director of the clinical epidemiology program at the Ottawa Hospital Research Institute. His clinical research interest are mainly in the field of transfusion medicine with a focus on transfusion alternatives and the effectiveness of blood products. Please view Dr. Fergusson’s publications here.  

    ICTMG connections:  Dr. Fergusson is the chair of the Methods Committee, and a member of the Executive and the Editorial committees. He is also a member of the guideline development group for platelets.

  • Mark Fung, MD, PhD, @MarkFungMDPhD

    University of Vermont Medical Center
    United States

    Expertise:  Dr. Fung is a pathologist with expertise in transfusion medicine and HLA. His research interests include transfusion medicine/blood banking and HLA platelet compatibility. Please view Dr. Fung’s publications here.   

    ICTMG connections:  Dr. Fung is the chair of the Editorial Committee, and a member of the Executive, Topics, and Dissemination and Implementation committees.  He is also a member of the guideline development group for platelets.

  • Laura Green, MBBS, MD (Res), FRCP, FRCPath

    NHS Blood and Transplant
    United Kingdom

    Expertise:  Dr. Green is a consultant hematologist with joint appointments at NHS Blood and Transplant, and Barts Health Trust.  Her research focuses on improving transfusion management of bleeding patients.

    ICTMG connections:  Dr. Green is a member of the Editorial Committee.

  • Andreas Greinacher

    University of Greifswald
    Germany

    Expertise:  Dr. Greinacher is a transfusion medicine specialist. His research interests include hereditary and immune mediated thrombocytopenias, especially heparin-induced thrombocytopenia. Please view Dr. Greinacher’s publications here.   

    ICTMG connections:  Dr. Greinacher is a member of the Editorial and the Topics committees, the co-chair of the guideline development group for fetal/neonatal alloimmune thrombocytopenia (FNAIT) and a member of the guideline development group for platelets.

  • Heather Hume, MD, FRCPC, MSc

    University of Montreal
    Canada

    Expertise:  Dr. Hume is a pediatric hematologist with a clinical research interest in non-malignant pediatric hematology and transfusion medicine. Please view Dr. Hume’s publications here

    ICTMG connections:  Dr. Hume is a member of the Dissemination and Implementation and the Topics committees. She is a member of the guideline development groups for fetal/neonatal alloimmune thrombocytopenia (FNAIT) and platelets. 

  • Rachel Jug, MB, BCh, BAO

    Canadian Blood Services
    Canada

    Expertise:  Dr. Jug is a pathologist and transfusion medicine trainee.

    ICTMG connections:  Dr. Jug is a trainee.  She is a member of the Topics Committee, and a member of the Guideline Development Group for the platelet AGREE II systematic review.

  • Richard Kaufman, MD, @RichardMKaufman
    Brigham & Women's Hospital Adult Transfusion Service
    United States

    Expertise:  Dr. Kaufman is medical director of the blood bank and transfusion service at the Brigham and Women’s Hospital in Boston and associate professor of pathology at Harvard Medical School. His research interests include blood banking, immunology, peripheral blood stem cell collection and transfusion medicine. Please view Dr. Kaufman’s publications here.

    ICTMG connections:  Dr. Kaufman is a member of the Editorial Committee. 

  • Hyungsuk Kim, MD
    Seoul National University Hospital
    Korea

    Expertise:  Dr. Kim is a clinical professor in laboratory medicine at Seoul National University College of Medicine. His research interest is mainly in the field of transfusion medicine with a focus on immunohematology. Please view Dr. Kim’s publications here

    ICTMG connections:  Dr. Kim is a member of the Dissemination and Implementation Committee. 

  • Ursula La Rocca, MD
    Italian National Blood Center and Sapienza, University of Rome
    Italy

    Expertise: Dr. La Rocca is a hematologist with research interests in immunohematology and transfusion medicine, pediatric hematology and hematopoietic stem cell transplantation.

    ICTMG connections:  Dr. La Rocca is a member of the guideline development group for hemolytic disease of the newborn (HDN). 

  • Lani Lieberman, MD
    University of Toronto
    Canada

    Expertise:  Dr. Lieberman is a transfusion medicine specialist and pediatric hematologist. Her research interests are transfusion medicine and benign hematology with a special interest in pediatric transfusion issues. 

    ICTMG connections:  Dr. Lieberman is a member of the Topics Committee, co-chair of the guideline development group for hemolytic disease of the newborn (HDN), and a member of the guideline development group for fetal/neonatal alloimmune thrombocytopenia (FNAIT). 

  • Vernon LouwMBChB (Stell), MMed(Int Med)(Stell), PhD(HPE)(UFS)
    Groote Schuur Hospital, University of Cape Town
    South Africa

    Expertise:  Dr. Louw is a clinical hematologist with interest in research and teaching in transfusion medicine education.

    ICTMG connections:  Dr. Louw is a member of the Topics Committee and is a member for the guideline development group for platelets. 

  • Tadashi Matsushita
    Nagoya University Hospital
    Japan

    Expertise:  Dr. Matsushita is a hematologist with a focus on clinical and basic research of blood coagulation and pathophysiology of thrombogenesis.

  • Michael Murphy, MD FRCP, FRCPath, FFPath, @MurphyProf
    University of Oxford and National Health Service Blood & Transplant
    United Kingdom

    Expertise: Dr. Murphy is a hematologist with a research interest in patient blood management and the implementation of measures, such as the use of technology, to improve the safety and effectiveness of transfusion practice.  Please view Dr. Murphy's publications here.

    ICTMG connections:  Dr. Murphy is the co-chair of the guideline development group for fetal/neonatal alloimmune thrombocytopenia (FNAIT), and a member of the guideline development group for platelets.

  • Susan Nahirniak, MD, @SusanNahirniak
    Alberta Precision Laboratories and University of Alberta
    Canada

    Expertise: Dr. Nahirniak is a hematopathologist. Her research interests focus on improving the appropriateness and quality of transfusion medicine. Please find Dr. Nahirniak’s publications here.

    ICTMG connections:  Dr. Nahirniak is a member of the Topics and the Methods committees and is co-chair of the guideline development group for platelets.

  • Katerina Pavenski, MD, FRCPC
    St. Michael's Hospital and University of Toronto
    Canada

    Expertise: Dr. Pavenski is clinical hematologist and head of the division of transfusion medicine at St. Michael’s Hospital in Toronto. Her research interests include clinical transfusion medicine, transfusion management of massive hemorrhage, and patient blood management. Please find Dr. Pavenski’s publications here.

    ICTMG connections:  Dr. Pavenski is the chair of the Topics Committee, a member of the Executive and the Dissemination and Implementation committees.  She is also a member of the guideline development group for platelets.

  • Joanne Pink, MBBS, FRACP, FRCPA, GAICD
    Australian Red Cross Lifeblood

    Australia

    Expertise: Dr. Pink is a hematologist and executive director, clinical services and research/chief medical officer at Australian Red Cross Lifeblood. Her research interests include donor and product safety. Please find Dr. Pink’s  publications here.

    ICTMG connections:  Dr. Pink is a member of the Editorial, Methods, Topics and the Dissemination and Implementation committees.  She is also a member of the guideline development group for platelets.

  • Susan Robinson, MBBS, FRACP, FRCPA, GAICD

    Guy's and St. Thomas' NHS Foundation Trust

    United Kingdom

    Expertise: Dr. Robinson is a consultant hematologist and clinical director. Her research interests include immunohematology, patient blood management, obstetric hematology and transfusion medicine. Please view Dr. Robinson’s publications here.

    ICTMG connections:  Dr. Robinson is a member of the Topics Committee, and a member of the guideline development groups for platelets and albumin.

  • Cynthia So-Osman, MD, PhD

    Sanquin and Erasmus Medical Center

    The Netherlands

    Expertise: Dr. So-Osman is a clinical consultant in transfusion medicine and hematology. Her research interests include clinical transfusion medicine, blood management, and evidence-based medicine. Please view Dr. So-Osman’s publications  here.

    ICTMG connections:  Dr. So-Osman is a member of the Methods Committee.

  • Simon Stanworth, MA, FRCP (Paeds, UK), PhD, FRCPath

    NHS Blood and Transplant and Oxford University

    United Kingdom

    Expertise: Dr. Stanworth is a consultant hematologist and honorary senior clinical lecturer at the University of Oxford. His research centres on clinical indications of blood transfusion components through systematic reviews and clinical studies. Please view Dr. Stanworth’s publications here.

    ICTMG connections:  Dr. Stanworth is the vice-chair of the ICTMG, co-chair of the Methods Committee, and a member of the Executive, Topics, and Editorial committees. He is also the co-chair for the guideline development group for platelets.

  • Zbigniew M. Szczepiorkowski, MD, PhD

    Dartmouth-Hitchcock Medical Center

    United States

    Expertise: Dr. Szczepiorkowski is professor of pathology and laboratory medicine, and medicine. His research interests include novel cellular therapies and an evidence-based approach to the use of therapeutic apheresis in clinical practice. Please view Dr. Szczepiorkowski’s publications here.

    ICTMG connections:  Dr. Szczepiorkowski is the co-chair of the Editorial Committee, and a member of the Executive, the Methods and the Dissemination and Implementation committees. He is also a member of the guideline development group for platelets.

  • Aaron Tobian, MD, PhD

    Johns Hopkins University 

    United States

    Expertise: Dr. Tobian is director of the transfusion medicine division and professor of pathology, medicine, oncology and epidemiology. His research interests include transfusion transmitted infections and HIV. Please view Dr. Tobian’s publications here.

    ICTMG connections:  Dr. Tobian is a member of the Editorial and the Topics committees, and is a member of the guideline development group for platelets.

  • Erica Wood, MBBS, FRACP, FRCPA

    Monash University
    Australia

    Expertise: Dr. Wood is a transfusion medicine specialist and consultant hematologist. Her research interests include hemovigilance and transfusion-transmitted infections. Please view Dr. Wood’s publications here.

    ICTMG connections:  Dr. wood is the co-chair of the Topics Committee, and a member of the Executive and the Editorial committees.  She is also a member of the guideline development groups for hemolytic disease of the newborn (HDN) and platelets.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

With funding provided by: